Breast Cancer Clinical Trial
Official title:
Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women
RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective
treatment for cancer. It is not yet known which type of mammography is more effective in
detecting breast cancer.
PURPOSE: Screening and diagnostic trial to compare the effectiveness of two types of
mammography in detecting breast cancer in women.
OBJECTIVES:
- Compare the diagnostic performance of digital mammography vs screen-film mammography, as
measured by the area under the Receiver Operating Characteristic (ROC) curve,
sensitivity, specificity, and positive and negative predictive values, in the detection
of breast cancer in women.
- Compare the diagnostic accuracy of the digital mammogram obtained using each of the
individual manufacturer's digital units vs screen-film mammography through retrospective
reader studies.
- Determine the effects of patient characteristics, including age, lesion type, pathologic
diagnosis, menopausal and hormonal status, breast density, and family history, on
diagnostic accuracy of digital mammography.
- Determine the effects of technical parameters, including display type, machine type, and
detector spatial and contrast resolution, on diagnostic accuracy of digital mammography.
- Determine the effect of reduced false-positive mammograms that are expected with digital
mammography on the health-related quality of life and personal anxiety of women
undergoing this screening experience.
- Compare the diagnostic performance of digital mammography with the rate of cancer in a
set of cases through a retrospective reader study.
- Compare the effect of softcopy vs printed film display on the diagnostic performance of
digital mammography through a retrospective reader study.
- Compare the effect of breast density on the diagnostic accuracy of digital mammography
vs screen-film mammography through a retrospective reader study.
- Compare the image quality and breast radiation dose in digital vs screen-film
mammography in these participants.
- Determine the temporal variations in image quality, breast radiation dose, and other
quality control parameters in the participating study centers.
OUTLINE: This is a randomized, multicenter study. Participants with postitive screening
results are stratified according to age (under 50 vs 50-59 vs 60-70 vs over 70). Participants
are randomized to one of two treatment arms.
- Arm I: Participants undergo a two-view screen-film mammogram followed by a two-view
digital mammogram of each breast.
- Arm II: Participants undergo a two-view digital mammogram followed by a two-view
screen-film mammogram of each breast.
Quality of life is assessed before the screening mammogram in the first 800 women enrolled.
In an additional 1,200 participants (600 with positive screening results and 600 with
negative screening results), quality of life is assessed shortly after the screening
mammogram and at 1 year.
Participants are followed at 1 year with a repeat screen-film or digital mammogram.
PROJECTED ACCRUAL: A total of 49,500 participants (24,750 per arm) will be accrued for this
study within 18 months.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |